20826-04-4
20826-04-4
Chemical Structure
5-Bromonicotinic acid
- CAS No.: 20826-04-4
- Formula:C6H4BrNO2
- Molecular Weight:202.01
IUPAC Name: 5-bromonicotinic acid
InChIKey: FQIUCPGDKPXSLL-UHFFFAOYSA-N
SMILES: O=C(C1=CC(Br)=CN=C1)O
Biological Activity: 5-Bromonicotinic acid is a brominated pyridinecarboxylic acid derivative of nicotinic acid, which serves as a pharmaceutical intermediate for organic synthesis-related research. 5-Bromonicotinic acid can form metal-organic frameworks (MOFs) with cadmium (II), cobalt (II) and lanthanide (III) salts[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
5-Bromonicotinic acid | 99.83% | 5-Bromonicotinic acid is a brominated pyridinecarboxylic acid derivative of nicotinic acid, which serves as a pharmaceutical intermediate for organic synthesis-related research. 5-Bromonicotinic acid can form metal-organic frameworks (MOFs) with cadmium (II), cobalt (II) and lanthanide (III) salts. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Bromonicotinic acid (Standard) | ≥98% | 5-Bromonicotinic acid (Standard) is the analytical standard of 5-Bromonicotinic acid (HY-Y1013). This product is intended for research and analytical applications. 5-Bromonicotinic acid is a brominated pyridinecarboxylic acid derivative of nicotinic acid, which serves as a pharmaceutical intermediate for organic synthesis-related research. 5-Bromonicotinic acid can form metal-organic frameworks (MOFs) with cadmium (II), cobalt (II) and lanthanide (III) salts. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Calahorro A J, et al. Novel metal–organic frameworks based on 5-bromonicotinic acid: Multifunctional materials with H₂ purification capabilities. CrystEngComm, 2012, 14(20): 6390-6393.
- [2]. Ruiz C, et al. Multifunctional coordination compounds based on lanthanide ions and 5-bromonicotinic acid: magnetic, luminescence and anti-cancer properties. CrystEngComm, 2019, 21(25): 3881-3890.
